Journal
/
Cancer Research
/
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

DOI:
10.3791/62811-v

•

08:02 min

•

September 23, 2021

•

, ,
1Department of Medicine III, School of Medicine,Technical University of Munich, 2Center for Translational Cancer Research (TranslaTUM), School of Medicine,Technical University of Munich, 3Department of Internal Medicine III,University Hospital Regensburg, 4National Centre for Tumor Diseases WERA

Chapters

  • 00:05Introduction
  • 00:48Generation and Isolation of Extracellular Vesicles (EVs) Derived from Tumor Cells After Chemotherapy Exposure
  • 02:59Immunization of C57BL/6 Mice with Extracellular Vesicles (EVs) and Flow Cytometry Analysis of Splenic T Cells
  • 06:01Results: The Assessment of the Immunogenicity of Tumor-Derived Extracellular Vesicles (EVs)
  • 07:21Conclusion

Summary

Automatic Translation

Automatic Translation

This manuscript describes how to assess in vivo immunogenicity of tumor cell-derived extracellular vesicles (EVs) using flow cytometry. EVs derived from tumors undergoing treatment-induced immunogenic cell death seem particularly relevant in tumor immunosurveillance. This protocol exemplifies the assessment of oxaliplatin-induced immunostimulatory tumor EVs but can be adapted to various settings.

Tags

Keywords: – Tumor-derived Extracellular Vesicles – Flow Cytometry – Splenic T Cells – In Vivo Immunogenicity Screening – B16 Melanoma Cells – Ovalbumin – Oxaliplatin – Ultracentrifugation – EV Isolation – Exosome Isolation Reagent – Immunization

Article

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

check_url/62811?article_type=v

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
check_url/62811?article_type=v

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment
check_url/62811?article_type=v

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
check_url/62811?article_type=v

Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
check_url/62811?article_type=v

A Spheroid Killing Assay by CAR T Cells
check_url/62811?article_type=v

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
check_url/62811?article_type=v

Extraction of Extracellular Vesicles from Whole Tissue
check_url/62811?article_type=v

Cell Cycle-specific Measurement of γH2AX and Apoptosis After Genotoxic Stress by Flow Cytometry
check_url/62811?article_type=v

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
check_url/62811?article_type=v

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Read Article